Jubilant Pharmova's Spokane Facility Classified VAI by USFDA

Jubilant Pharmova Limited announced that its subsidiary, Jubilant HollisterStier LLC's contract manufacturing organization (CMO) facility in Spokane, Washington, USA, has been classified as 'Voluntary Action Indicated' (VAI) by the USFDA. This classification follows the USFDA's review of the Establishment Inspection Report (EIR) for the inspection conducted between June 8-17, 2026. The VAI classification indicates that while the inspection identified some observations, they do not warrant a more severe regulatory action at this time. Jubilant HollisterStier is a key player in manufacturing sterile injectables and ophthalmics.